ASTH

Astrana Health, Inc. Industrials Services-Management Consulting Services Russell 3000
$36.53Close $1.8BMarket cap $18.16 – $49.8152-week range Nov 5, 2026Next report · after the close

Highlights

Strengths

  • Earnings growing EPS +108% year on year

Cautions

  • Not in an uptrend 4 of 8 trend conditions
  • Far from its high 27% below its 52-week high
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 10, 2026
Off 12-month high 27%
1wk down 2.5% price change
1mo up 2.7% price change
12-month return up 15% market up 11% · its own down 1%
F-score — — Not assessed
Altman Z″ 1.92 Moderate risk
P/E 74.4× price / earnings
PEG — P/E / EPS growth
P/B 2.3× price / book
Earnings yield up 3.3% EBIT / enterprise value
Cheaper than 62% of the market · cheap
Revenue growth up 56% year on year
EPS growth up 108% latest quarter · -7 pts
Sales growth up 49% latest quarter · -7 pts
ROE up 3% return on equity
Free cash margin up 3% $104.5M FCF
D/E 1.27 long-term debt / equity
Net debt / EBITDA 4.5×
Interest cover —EBIT / interest

Trade setup

ATR% 4.1% $1.50 a day · 2×ATR $33.53
RS 72 / 99 vs the universe
Trend 4 / 8 trend template
Relative volume 0.7× vs 50-day average
Up/down volume 0.88 50 sessions
Implied move — no option chain · report Nov 5, 2026
Trend template · 4 of 8
  • Price above the 150 and 200-day averages: fails
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: passes
  • 50-day average above the 150 and 200-day: fails
  • Price above the 50-day average: fails
  • At least 30% above the 52-week low: passes
  • Within 25% of the 52-week high: fails
  • RS rank 70 or higher: passes

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Heavily indebted Net debt is 4.5 times EBITDA — roughly 5 years of earnings before interest, tax and depreciation to repay borrowings in full.
Last reported Aug 6, 2026
Last shock Sep 17, 2026-9% in one session2.3× volumeon an SEC filing+7% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $3.2B +56% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $687.2M FY2021 · $773.9M FY2022 · $1.1B FY2023 · $1.4B FY2024 · $2.0B FY2025 · $3.2B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $24.0M -52% on FY2024
$0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $37.7M FY2021 · $46.0M FY2022 · $46.0M FY2023 · $58.0M FY2024 · $50.0M FY2025 · $24.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $104.5M +137% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $45.0M FY2021 · $51.1M FY2022 · $59.2M FY2023 · $39.7M FY2024 · $44.2M FY2025 · $104.5M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross
  • Net 1%
  • Free cash 3%
0% 25% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 22% · Net 5% · Free cash 7% FY2021 · Gross 23% · Net 6% · Free cash 7% FY2022 · Net 4% · Free cash 5% FY2023 · Net 4% · Free cash 3% FY2024 · Net 2% · Free cash 2% FY2025 · Net 1% · Free cash 3%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $561.4M net debt
  • Cash
  • Long-term debt
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $193.5M · Long-term debt $230.2M FY2021 · Cash $233.1M · Long-term debt $182.9M FY2022 · Cash $288.0M · Long-term debt $203.4M FY2023 · Cash $293.8M · Long-term debt $258.9M FY2024 · Cash $288.5M · Long-term debt $425.3M FY2025 · Cash $429.5M · Long-term debt $990.9M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 48.89m +15.7% since FY2020
48.89m 42.25m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 42.25m FY2021 · 44.63m FY2022 · 46.58m FY2023 · 46.84m FY2024 · 47.93m FY2025 · 48.89m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $687.2M $773.9M $1.1B $1.4B $2.0B $3.2B
Gross margin 22% 23% — — — —
Operating income $80.5M $98.2M $104.3M $84.6M $89.3M $78.5M
Net income $37.7M $46.0M $46.0M $58.0M $50.0M $24.0M
Net margin 5% 6% 4% 4% 2% 1%
Earnings per share $1.01 $1.01 $1.01 $1.24 $1.04 $0.49
Free cash flow $45.0M $51.1M $59.2M $39.7M $44.2M $104.5M
Free cash margin 7% 7% 5% 3% 2% 3%
Cash $193.5M $233.1M $288.0M $293.8M $288.5M $429.5M
Long-term debt $230.2M $182.9M $203.4M $258.9M $425.3M $990.9M
Shareholders' equity $330.8M $448.2M $542.6M $614.2M $712.7M $779.3M
Shares outstanding 42.25m 44.63m 46.58m 46.84m 47.93m 48.89m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 10, 2026 Quarterly ↗ Jun 30, 2026 41d
May 8, 2026 Quarterly ↗ Mar 31, 2026 38d
Mar 12, 2026 Annual ↗ Dec 31, 2025 71d
Nov 10, 2025 Quarterly ↗ Sep 30, 2025 41d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 9, 2025 Quarterly ↗ Mar 31, 2025 39d
Mar 14, 2025 Annual ↗ Dec 31, 2024 73d
Nov 12, 2024 Quarterly ↗ Sep 30, 2024 43d
Aug 9, 2024 Quarterly ↗ Jun 30, 2024 40d
May 9, 2024 Quarterly ↗ Mar 31, 2024 39d
Feb 29, 2024 Annual ↗ Dec 31, 2023 60d
Nov 9, 2023 Quarterly ↗ Sep 30, 2023 40d

Current reports